Back to search

Netherlands· NL-76dc0660c523

Cervarix, suspensie voor injectie

A humaner papillomvirus (typen 16, 18) product containing recombinant humaan papillomavirus type 16-l1 proteïne + recombinant humaan papillomavirus type 18-l1 proteïne, registered in Netherlands by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC J07BM02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCervarix, suspensie voor injectieATCJ07BM02REGISTER NO.NL-76dc0660c523PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Humaner papillomvirus (typen 16, 18) is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BM02 (humaner papillomvirus (typen 16, 18)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Humaner papillomvirus (typen 16, 18) · ATC J07BM02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 16-L1 PROTEÏNE + RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 18-L1 PROTEÏNE
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Netherlands (NL)
ATC code
J07BM02
ATC class
Humaner Papillomvirus (Typen 16, 18)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/07/419

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df8c661c-2f54-4527-b41b-be9ae41356cc
GET /v1/drugs/df8c661c-2f54-4527-b41b-be9ae41356cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cervarix-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Papillomavirus (human types 16, 18)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73202",
  "excipients": [
    "3-O-DESACYL-4'-MONOFOSFORYLLIPIDE A",
    "ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 16-L1 PROTEÏNE",
    "RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 18-L1 PROTEÏNE"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/09/20",
  "procedure_number": "EMEA/H/C/000721",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/07/419",
  "additional_monitoring": "N"
}

See everything about humaner papillomvirus (typen 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.